Expression of vascular endothelial growth factor in human gallbladder lesions

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1065-1069

  Yamamoto, Shigeru ^a   Fujii, Kiyomu ^a   Kitadai, Yasuhiko ^a   Yamamoto, Soichiro ^a   Tsuchida, Akira ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Gallbladder carcinoma; Immunohistochemistry; In situ mRNA hybridization; Vascular endothelial growth factor

Indexed keywords

CYCLINE; MESSENGER RNA; VASCULOTROPIN;

ADENOMA; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GALLBLADDER CARCINOMA; GALLBLADDER DISEASE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031858308     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1065     Document Type: Article

References (41)

1. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 785: 1182-1186, 1971.
2. Folkman J, Watoson K, Ingber D and Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61, 1989.
3. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 84: 1875-1887, 1992.
4. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19, 1995.
5. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS and White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 145: 510-514, 1994.
6. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R and Iki M: Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56: 2671-2676, 1996.
7. Fidler JJ and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994.
8. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG and Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
9. Tsai J-C, Goldman CK and Gillespie GY: Vascular endothelial growth factor in human glioma cell lines; induced secretion by EGF, PDGF-BB and bFGF. J Neurosurg 82: 864-873, 1995.
10. Leung DW, Cachianes G, Kuang W-J, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
11. Ferrara N, Houck K, Jakeman L and Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18-32, 1992.
12. Brese B, Brown L, Van de Water L, Dvorak H and Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3: 211-220, 1992.
13. de Vries C, Escobido JA, Ueno H, Houck K, Ferrara N and Williams LT: The fms-like thyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992.
14. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
15. Albores-Saavedra J, Henson DE and Sobin LH: Histological typing of tumors of the gallbladder carcinoma and extrahepatic bile ducts. In: WHO International Histological Typing of Tumors. Springer, Berlin, 1992.
16. Beahrs OH, Henson DE, Hutter RVP, et al (eds): Manual for Staging of Cancer. 4th edition. J.B. Lippincott, Philadelphia, 1992.
17. WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol 180: 122-128, 1996.
18. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
19. Hanada K, Itoh M, Fujii K, Tsuchida A, Ishimaru S, Hirata M and Kajiyama G: Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder and its relationship to prognosis. Scand J Clin Lab Invest 55: 377-382, 1995.
20. Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E and Fidler IJ: In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am J Pathol 147: 1238-1247, 1995.
21. Yamamoto So, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G and Tahara E: Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int (In press).
22. Toi M, Inada K, Suzuki H and Tominaga T: Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204, 1995.
23. Maeda K, Chung Y-S, Ogawa Y, Takatsuka S, Kang S-M, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996.
24. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP and Kreutzer DL: Vascular endothelial growth factor (VECF) expression in human prostate cancer. J Urol 157: 2329-2333, 1997.
25. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF and Ramakrishnan S: Vascular endothelial growth factor expression in early ovarian carcinoma. Cancer 80: 98-106, 1997.
26. Rak J, Mitsuhashi Y, Bayoko L, Filmus J, Shirasawa S, Sasazuki T and Kerbel RS: Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for inducation and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580, 1995.
27. Kieser A, Weich HA, Brandner G, Marmé D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994.
28. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S and Saitoh Y: K-ras mutation in gall bladder carcinomas and hyperplasia. Gut 38: 426-429, 1996.
29. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H and Kajoyama G: K-ras and p53 Mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 77: 452-458, 1996.
30. Fujii K, Yokozaki H, Yasui W, Kuniyasu H, Hirata M, Kajiyama G and Tahara E: High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers 5: 461-466, 1996.
31. Dolecki GJ and Connolly DT: Effects of a variety of cytokines and inculuding agents on vascular permability factor mRNA levels in U973 cells. Biochem Biophys Res Commun 180: 572-578, 1991.
32. Brogi E, Wu T, Namiki A and Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994.
33. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O and Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor β in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274, 1994.
34. Kim K-W, Bae S-K, Lee O-H, Bae M-H, Lee M-J and Park BC: Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58: 348-351, 1998.
35. Li J, Perrella MA, Tsai J-C, Yet S-F, Hsieh C-M, Yoshizumi M, Patterson C, Endege WO, Zhou F and Lee M-E: Inducation of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem 270: 308-312, 1995.
36. Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
37. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD and Ellis LM: Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinaltype gastric cancer. Clin Cancer Res 2: 1679-1684, 1996.
38. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Claery KR and Ellis LM: Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132: 541-546, 1997.
39. Tanimoto H, Yoshida K, Yokozaki H, Yasui W, Nakayama ZH, Ito H, Ohama K and Tahara E: Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch 61: 263-267, 1991.
40. Kitadai Y, Haruma K, Sumii K, Yamamoto So, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler U and Tahara E: Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152: 93-100, 1998.
41. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.